BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 214 found
  Current Search:  gleevec: 214     

HTML
100%
Pharma cos hit by new Patent Act concoction, filings drop 41%
MUMBAI: Patent applications filed by Indian pharma firms have witnessed a sharp fall of 41% during FY08.

Data provided by the Controller General of Patents shows that only 449 patent applications were filed in 2007-08 compared to 765 filed...

Economictimes:  Jul 6 2008 10:19PM
Matching: gleevec
Find similar documents
HTML
100%
Costly Cancer Drug Offers Hope, but Also a Dilemma
EXPERIMENTAL TREATMENT After participating in a clinical trial comparing Avastin with another new drug, Gailanne Reeh continued the regimen.

Josh Haner/The New York Times It took only an instant for 58-year-old Gailanne Reeh to go from the...

Hendersonville Times News:  Jul 6 2008 12:31PM
Matching: gleevec
Find similar documents
HTML
100%
Cancer drug Avastin has arguable benefits
It took only an instant for 58-year-old Gailanne Reeh to go from the picture of health to death's door.

By chance, her doctor noticed a lump under her arm during a routine exam.

It turned out to be advanced breast cancer.

The surgeon,...

Commercial Appeal:  Jul 6 2008 8:57AM
Matching: gleevec
Find similar documents
HTML
100%
For a big price, cancer drug buys small amount of time
It took only an instant for 58-year-old Gailanne Reeh to go from the picture of health to death's door.

By chance, her doctor noticed a lump under her arm during a routine exam.

It turned out to be advanced breast cancer.

Then the...

Chicago Tribune:  Jul 6 2008 3:56AM
Matching: gleevec
Find similar documents
HTML
100%
Novartis Gold Mine shot may stop killer meningitis
Novartis AG biologist Rino Rappuoli says he may have found a way to wipe out meningitis B, a disease that can kill children within 24 hours of infection.

Fifteen years after Rappuoli undertook his meningitis project, Basel, Switzerland...

Checkbiotech:  Jul 4 2008 7:48AM
Matching: gleevec
Find similar documents
HTML
100%
Heart failure linked to sunitinib treatment
NEW YORK (Reuters Health) - In a study published in the June 1st issue of Cancer, researchers report the development of symptomatic heart failure in nearly 3% of cancer patients soon after starting treatment with the multitargeted tyrosine...
Clinical Lab Products:  Jul 3 2008 11:20AM
Matching: gleevec
Find similar documents
HTML
100%
TopAbstracts in Leukemias 07/02/2008
TopAbstracts in Leukemias are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.

Over 2000 peer-reviewed...

Doctors Guide:  Jul 3 2008 6:46AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application For SGX393
SGX Pharmaceuticals recently announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an internally developed, selective, orally-bioavailable...

Pharmaceutical Online:  Jul 1 2008 7:36AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO The standard of care for CML is Gleevec(R).

Although Gleevec is a highly effective front-line therapy for CML, there are patients who relapse while on Gleevec or who are intolerant to the therapy.

In the majority of...

DiGiTAL50:  Jul 1 2008 5:48PM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
/PRNewswire-FirstCall/ -- SGX Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an internally developed, selective,...

Pharma Live:  Jul 1 2008 9:25AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SGX Pharmaceuticals (NASDAQ:SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an internally developed, selective, orally...

Freshnews.com:  Jun 30 2008 6:11PM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP - News) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound...

Yahoo! Canada:  Jun 30 2008 10:36AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP - News) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound...

PR Newswire via Yahoo!:  Jun 30 2008 10:08AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
San Diego The standard of care for CML is Gleevec(R).

Although Gleevec is a highly effective front-line therapy for CML, there are patients who relapse while on Gleevec or who are intolerant to the therapy.

In the majority of...

Atlas Venture:  Jun 30 2008 9:54PM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an internally...

KOTA Territory News:  Jun 30 2008 5:01PM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Nashville Business Journal:  Jun 30 2008 10:59AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Business Journal of Milwaukee:  Jun 30 2008 10:58AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals SGXP today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an internally...

Houston Chronicle:  Jun 30 2008 10:55AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Biz Journals:  Jun 30 2008 10:52AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
, 2:00 AM EST The standard of care for CML is Gleevec(R).

Although Gleevec is a highly effective front-line therapy for CML, there are patients who relapse while on Gleevec or who are intolerant to the therapy.

In the...

Genetic Engineering News:  Jun 30 2008 10:44AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

San Antonio Business Journal:  Jun 30 2008 10:44AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

San Francisco Business Times:  Jun 30 2008 10:27AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Portland Business Journal:  Jun 30 2008 10:24AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Street Insider:  Jun 30 2008 10:24AM
Matching: gleevec
Find similar documents
HTML
100%
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S.

Food and Drug Administration for SGX393.

This compound is an...

Columbus Business First:  Jun 30 2008 10:21AM
Matching: gleevec
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.